期刊文献+

CD_(105)和F-8RAg在乳腺癌的表达及其生物学行为的关系

The Correlation Between Expression of CD_(105)and F-8RAg in Breast Cancer and Its Biological Behavior
原文传递
导出
摘要 目的观察CD105在乳腺癌的表达和探讨CD105与乳腺癌生长侵袭转移的关系。方法采用免疫组化S-P法,检测50例乳腺浸润性导管癌,20例乳腺导管内癌,20例乳腺良性增生组织CD105和F-8RAg标记的微血管密度。结果CD105的表达在乳腺浸润性导管癌明显高于乳腺导管内癌及乳腺良性增生组织(P值均<0.01)。F-8RAg的表达在乳腺浸润性导管癌和导管内癌中MVD均明显高于良性增生组织(P<0.01)。在乳腺浸润导管癌组织中CD105与F-8RAg的表达存在显著性差异(P<0.01),乳腺导管内癌和良性增生组织中CD105与F-8RAg的表达无显著性差异(P>0.05)。结论CD105在乳腺癌的表达与其生长侵袭和转移密切相关,癌组织中MVD计数明显优于F-8RAg。 Objective To observe the expression of CD_ 105 in breast cancer, and explore the correlation between CD_ 105 and growth, invasion and metabasis of breast cancer. Methods 50 cases of breast infiltrating duct cancer, 20 cases of breast duct cancer and 20 cases of breast benign hyperplasia were enrolled in this study. The microvascular density(MVD) was marked with CD_ 105 and F-8RAg using immunohistochemical S-P method. Results The expression level of CD_ 105 in breast infiltrating duct cancer was significantly higher than that in breast duct cancer and benign hyperplasisa(P<0.01). The expression level of F-8RAg in breast infiltrating duct cancer and duct cancer was obviously higher than that in breast benign hyperplasia. There were significant differences between the expression rates of CD_ 105 and F-8RAg in breast infiltrating duct cancer(P<0.01), and not significant differences in breast duct cancer and benign hyperplasisa. Conclusion The expression of CD_ 105 in breast cancer was closely related to the growth,invasion and metabasis of breast cancer. CD_ 105 was more sensitive than F-8RAg in counting MVD of breast cancer.
出处 《中国医师杂志》 CAS 2005年第7期910-911,共2页 Journal of Chinese Physician
关键词 CD105 F-8RAg 乳腺癌 表达 生物学行为 Breast neoplasm CD_105 Microvascular density Immunohistochemistry
  • 相关文献

参考文献8

  • 1Wikstrom P, Lissbrant IF, Stattin P, et al. CD105 is expressed on immature blood vessels and is a marker for survival in prostate cancer[J]. Prostate, 2002, 51(4):268-275
  • 2熊正文,王炳胜,朱光君,苏红,李春光,安赵栓.CD_(34)、CD_(31)与F_(Ⅷ)显示非小细胞肺癌微血管密度的对比研究[J].中国医师杂志,2003,5(4):438-441. 被引量:22
  • 3Gomez-Esquer F,Agudo D,Martinez-Arribas F,et al.mRNA expression of the angiogenesis markers VEGF and CD105 in human breast cancer[J].Anticancer Res,2004,24(3):1581-1585
  • 4Akagi K, lkeda Y, Su miyoshi Y, et al. Estimation of angiogenesis with anti-CD105 immnostaing in the process of colorectal cancer development[J]. Surgery , 2002 , 131 (1 Suppl):S109-113
  • 5Tanaka F, Otake Y, Yanagihara K, et al . Evaluation of angiogenesis in non-small cell lung cancer : comparison between anti-CD34 antibody and anti-CD105 antibody[J]. Clin Cancer Res , 2001 , 7(11):3410-3415
  • 6Takahashi N,Kavanishi-Tabata R,Haba A,et al.Association of serum endoglin with matastisis in patients with colorectal,breast,and other solid tumours,and suppressive effect of chemotherapy on the serum endoglin[J].Clin Cancer Res, 2001,7(3):524-532
  • 7Fumihiro Tanaka, et al.Correlalion Betneen apoptotic index and agiogenesis in noe-smell cell lung Cancer:comparison between CD105 and CD34 as a maker as agiogenesis[J]. Lung Cancer, 2003 ,39:289-296
  • 8Saad RS,Jasnosz KM,Tung MY,et al.CD105 expression in endometrial carcinoma[J].Int J Gynecol Pathol,2003,22(3):248-253

二级参考文献2

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部